We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Information to support your recovery after COVID-19.
How to use a cost benefit analysis to evaluate your digital health product.
Details of sediment and sample analysis for marine licence applications.
The Government Digital Service (GDS) user research lab is currently closed until further notice.
The Agency carried out animal disease surveillance, diagnostic services and veterinary scientific research for government and commercial organisations. It was merged with Animal Health in 2011 to form the Animal Health and Veterinary Laboratories Agency.
The CDRN laboratory provides timely access to Clostridioides difficile culture, ribotyping and DNA fingerprinting services, according to standardised submission criteria.
Business rates information letters are issued by the Department for Levelling Up, Housing and Communities at regular intervals throughout the year.
How to use a before-and-after study to evaluate your digital health product.
Find out how to take samples from processed ABPs and find laboratories to test them, and what to do if one of your samples fails a test.
Guidance for UK companies on winning business from international aid and development projects.
There are different regulations which apply to devices and equipment including hand gels and PPE (personal protective equipment)
How to check that a laboratory is allowed to buy ozone-depleting substances (ODS).
Find out about the long-term effects some people can have after having COVID-19.
Information about when you need to submit substantial amendments to a clinical trial including changes to the trial sponsor or legal representative, Investigational medicinal product certification and importation.
The CDRN laboratory provides access to Clostridioides difficile culture, ribotyping and enhanced fingerprinting services, according to standardised submission criteria.
This toolkit is for Innovation Passport holders following the Innovative Licensing and Access Pathway (ILAP) and provides activities to support the design and development of medicines.
Guidance on the collection and reporting of data for CTAD, the surveillance system for all chlamydia tests done in England.
How the MHRA makes decisions on when a product is a medical device (borderline products), and which risk class should apply to a medical device.
The Government Chemist team has published guidance on analytical limits for controlled cannabinoids in specified products containing cannabidiol (CBD)
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.